News

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs
Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the first ...
Income Strategy: I'm Buying 2 Elite Mispriced Dividends
Learn More » This brings me to the following 2 picks, both of which have long track records of capital returns to ...
Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut
Pfizer increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and “confidence” that strength seen in the first ...
Free Malaysia Today on MSN18m
Pfizer’s earnings boosted by Covid-19 products, lower expenses
Pfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices.
Vertex Stock Tumbles 15% After Strong Earnings. What’s Spooking Investors.
Vertex Pharmaceuticals stock fell after quarterly earnings and revenue beat analysts’ expectations, overshadowed by bad news ...
Y-mAbs stock soars after SERB Pharmaceuticals announces acquisition
Investing.com -- Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) stock surged 103% following the announcement that SERB Pharmaceuticals will acquire the company in an all-cash transaction valued at ...